Literature DB >> 23554418

Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Vered Schechner1, Elizabeth Temkin, Stephan Harbarth, Yehuda Carmeli, Mitchell J Schwaber.   

Abstract

Bacterial resistance to antibiotics is a growing clinical problem and public health threat. Antibiotic use is a known risk factor for the emergence of antibiotic resistance, but demonstrating the causal link between antibiotic use and resistance is challenging. This review describes different study designs for assessing the association between antibiotic use and resistance and discusses strengths and limitations of each. Approaches to measuring antibiotic use and antibiotic resistance are presented. Important methodological issues such as confounding, establishing temporality, and control group selection are examined.

Mesh:

Substances:

Year:  2013        PMID: 23554418      PMCID: PMC3623381          DOI: 10.1128/CMR.00001-13

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  186 in total

1.  The use and interpretation of quasi-experimental studies in infectious diseases.

Authors:  Anthony D Harris; Douglas D Bradham; Mona Baumgarten; Ilene H Zuckerman; Jeffrey C Fink; Eli N Perencevich
Journal:  Clin Infect Dis       Date:  2004-05-12       Impact factor: 9.079

2.  The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting.

Authors:  Alexandre R Marra; Silvana Maria de Almeida; Luci Correa; Moacyr Silva; Marinês Dalla Valle Martino; Cláudia Vallone Silva; Ruy Guilherme Rodrigues Cal; Michael B Edmond; Oscar Fernando Pavão dos Santos
Journal:  Am J Infect Control       Date:  2008-11-04       Impact factor: 2.918

Review 3.  Interventions to control MRSA: high time for time-series analysis?

Authors:  S Harbarth; M H Samore
Journal:  J Antimicrob Chemother       Date:  2008-06-12       Impact factor: 5.790

4.  Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study.

Authors:  A J Clavo-Sánchez; J A Girón-González; D López-Prieto; J Canueto-Quintero; A Sánchez-Porto; A Vergara-Campos; P Marín-Casanova; J A Córdoba-Doña
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

5.  Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation.

Authors:  D A Schiappa; M K Hayden; M G Matushek; F N Hashemi; J Sullivan; K Y Smith; D Miyashiro; J P Quinn; R A Weinstein; G M Trenholme
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

6.  The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital.

Authors:  Aurora E Pop-Vicas; Erika M C D'Agata
Journal:  Clin Infect Dis       Date:  2005-05-06       Impact factor: 9.079

7.  Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.

Authors:  Peter W Kim; Anthony D Harris; Mary-Claire Roghmann; J Glenn Morris; Arjun Strinivasan; Eli N Perencevich
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

Authors:  E P Hyle; M J Ferraro; M Silver; H Lee; D C Hooper
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10-28       Impact factor: 3.254

9.  Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli.

Authors:  R Colodner; I Kometiani; B Chazan; R Raz
Journal:  Infection       Date:  2008-01-12       Impact factor: 3.553

10.  Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections.

Authors:  Joshua P Metlay; Brian L Strom; David A Asch
Journal:  J Antimicrob Chemother       Date:  2003-02-25       Impact factor: 5.790

View more
  47 in total

1.  Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013.

Authors:  Amos Adler; Na'ama Sturlesi; Noga Fallach; Deniz Zilberman-Barzilai; Omar Hussein; Shlomo E Blum; Eyal Klement; Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

2.  Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis.

Authors:  M-A Vibet; J Roux; E Montassier; S Corvec; M-E Juvin; C Ngohou; D Lepelletier; E Batard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-24       Impact factor: 3.267

Review 3.  Antimicrobial use and antimicrobial resistance in food animals.

Authors:  Wenguang Xiong; Yongxue Sun; Zhenling Zeng
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-25       Impact factor: 4.223

4.  Interventions to Improve Antimicrobial Stewardship for Older People in Care Homes: A Systematic Review.

Authors:  Hoa Q Nguyen; Michael M Tunney; Carmel M Hughes
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

5.  Trends in Collection of Microbiological Cultures Across Veterans Affairs Community Living Centers in the United States Over 8 Years.

Authors:  Haley J Appaneal; Aisling R Caffrey; Maria-Stephanie A Hughes; Vrishali V Lopes; Robin L P Jump; Kerry L LaPlante; David M Dosa
Journal:  J Am Med Dir Assoc       Date:  2019-08-26       Impact factor: 4.669

6.  Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.

Authors:  Q Wang; Y Zhang; X Yao; H Xian; Y Liu; H Li; H Chen; X Wang; R Wang; C Zhao; B Cao; H Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-11       Impact factor: 3.267

7.  De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU.

Authors:  Jean-Francois Timsit; Stephan Harbarth; Jean Carlet
Journal:  Intensive Care Med       Date:  2014-09-17       Impact factor: 17.440

Review 8.  Methods and issues in studies of CRE.

Authors:  Scott R Evans; Anthony D Harris
Journal:  Virulence       Date:  2016-07-28       Impact factor: 5.882

Review 9.  Examining the relationship between multidrug-resistant organism acquisition and exposure to antimicrobials in long-term care populations: a review.

Authors:  Michele L Shaffer; Erika M C D'Agata; Daniel Habtemariam; Susan L Mitchell
Journal:  Ann Epidemiol       Date:  2016-09-23       Impact factor: 3.797

Review 10.  Update on the adverse effects of antimicrobial therapies in community practice.

Authors:  Samiha Mohsen; James A Dickinson; Ranjani Somayaji
Journal:  Can Fam Physician       Date:  2020-09       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.